Table 1 Sample characteristics of TCM users and TCM nonusers among lung cancer patients
Characteristics | Overall | TCM nonusers | TCM users | P-value |
|---|---|---|---|---|
Sex, n (%) | ||||
 Male | 31,371 (66.2) | 5525 (63.5) | 25,864 (66.8) | < 0.001 |
 Female | 16,022 (33.8) | 3171 (36.5) | 12,851 (33.2) | |
Age (years), median (IQR) | 64 (57–73) | 63 (55–71) | 65 (57–73) | < 0.001 |
Age group, n (%) | ||||
 0–39 | 1024 (2.2) | 297 (3.4) | 727 (1.9) | < 0.001 |
 40–59 | 16,160 (34.1) | 3297 (37.9) | 12,863 (33.2) | |
 60–69 | 15,514 (32.7) | 2714 (31.2) | 12,800 (33.1) | |
 70–79 | 11,703 (24.7) | 1907 (21.9) | 9796 (25.3) | |
 ≧80 | 2992 (6.3) | 481 (5.5) | 2511 (6.5) | |
Insurance type, n (%) | ||||
 UEBMI | 36,149 (76.3) | 6665 (76.6) | 29,484 (76.2) | 0.370 |
 URBMI | 11,244 (23.7) | 2031 (23.4) | 9213 (23.8) | |
Hospital level, n (%) | ||||
 Primary | 2044 (4.3) | 337 (3.9) | 1707 (4.4) | < 0.001 |
 Secondary | 12,504 (26.4) | 1869 (21.5) | 10,635 (27.5) | |
 Tertiary | 32,845 (69.3) | 6490 (74.6) | 26,355 (68.1) | |
Region, n (%) | ||||
 East | 23,334 (49.2) | 4945 (56.9) | 18,389 (47.5) | < 0.001 |
 Central | 11,655 (24.6) | 1883 (21.7) | 9772 (25.3) | |
 West | 12,404 (26.2) | 1868 (21.5) | 10,536 (27.2) | |
No of comorbidities, n (%) | ||||
 0 | 35,432 (74.8) | 6437 (74.0) | 28,995 (74.9) | 0.001 |
 1 | 5824 (12.3) | 1119 (12.9) | 4705 (12.2) | |
 2 | 4778 (10.1) | 934 (10.7) | 3844 (9.9) | |
 ≧3 | 1359 (2.9) | 206 (2.4) | 1153 (3.0) | |
ALOS per time | 13.0 | 9.8 | 13.9 | < 0.001 |
Year, n (%) | ||||
 2010 | 4009 (8.5) | 911 (10.5) | 3098 (8.0) | < 0.001 |
 2011 | 5789 (12.2) | 1398 (16.1) | 4391 (11.4) | |
 2012 | 5307 (11.2) | 1237 (14.2) | 4070 (10.5) | |
 2013 | 7486 (15.8) | 1371 (15.8) | 6115 (15.8) | |
 2014 | 7254 (15.3) | 1080 (12.4) | 6174 (16.0) | |
 2015 | 7987 (16.9) | 1181 (13.6) | 6806 (17.6) | |
 2016 | 9561 (20.2) | 1518 (17.5) | 8043 (20.8) | |
Number of patients, n (%) | 47,393 (100.0) | 8696 (18.3) | 38,697 (81.7) | |